Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Michael Pins

Adjuvant Sunitinib or Sorafenib for High-Risk, Non-Metastatic Renal-Cell Carcinoma (ECOG-ACRIN E2805): A Double-Blind, Placebo-Controlled, Randomised, Phase 3 Trial

English

Eastern Cooperative Oncology Group Phase II Trial of Lapatinib in Men With Biochemically Relapsed, Androgen Dependent Prostate Cancer

Urologic Oncology: Seminars and Original Investigations

English